EasyM is developed by Rapid Novor.

About Us.

The EasyM™ test is developed by Rapid Novor, a Canadian biotech company founded in 2015. The proteomics mass spectrometry and bioinformatics technology we have pioneered has empowered thousands of researchers across the world to develop diagnostics, reagents and therapeutics..

EasyM™ is Rapid Novor’s first proprietary clinical application of our established protein sequencing technology.

Our vision is to elevate human health by decoding immunity and our team is committed to championing better testing for patients with Multiple Myeloma.

Meet our Myeloma Team.

Meet our Myeloma Team.

Dr. Bin Ma
Dr. Bin MaPresident & Chief Scientist
Dr. Liqiang Yang
Dr. Liqiang YangChief Strategy Officer
Dr. Don Xu
Dr. Don XuClinical Lab Director
Dr. Zac McDonald
Dr. Zac McDonaldSenior Research Scientist
Dr. Mariya Liyasova
Dr. Mariya LiyasovaResearch Scientist
Dr. Abir Khaled
Dr. Abir KhaledResearch Scientist
Mingjie Xie
Mingjie XieChief Executive Officer
Iain Rogers
Iain RogersVP Sales and Marketing
Anthony Stajduhar
Anthony StajduharDirector of Business Development
Weihao Tang, MSc
Weihao Tang, MScSr. Marketing Manager, Hematology

Supporting Multiple Myeloma in Our Community.

Every year, our team meets up with our local Multiple Myeloma community in Kitchener, Ontario for the annual Multiple Myeloma March organized by Myeloma Canada. We walk 5km and we raise thousands of dollars for MM research. More importantly, we come together with clinicians, patients with MM, families and others who care about the cause. It’s a great chance for us all to connect.

With greater awareness and innovative research, we can all help provide those living with this disease with the best available therapies so that they can enjoy these precious moments with their friends and families. Visit https://support.myeloma.ca/ for more information.